TommyBoyTrader

[stockforce]

$RXMD .20 tomorrow morning, testing .30 in the afternoon. Armen is working on their 2021 Shareholder’s Letter right now. It could come out this week. Another record breaking January revenue with a potential 200+% 340B revenue increase. The ClearMetrx data analysis and management service revenue is fast growing and is mostly free of PBM fees with a possible 50-70% profit margin. MyVax COVID partnership is expanding into Telehealth. The audited 2020 financials of $40.6M revenue will be completed by the end of March. Most importantly, the S-1 for Nasdaq uplist and a highly possible major M&A could be announced at any time. RXMD will easily surpass the all time high .26 this week. If these news can be aligned properly, 50c to $1 will be very well within reach in a very short term.